To investigate whether HNRNPA2B1 induced endocrine resistance in breast cancer cells, researchers constructed HNRNPA2B1‐overexpressed MCF‐7 cells (formerly tamoxifen sensitive). Here, HNRNPA2B1 is linked to breast cancer.